AUPH
AURINIA PHARMACE
Health Care·Biotechnology·CANADA
$17.23
MCap $2.2B
as of 2026-06-26
Total
B1w
Fund
A1w
Quant
C1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-27
MIDOS SI
-0.79
Sentiment 87.0%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$17.23
Adaptive Mean
$17.88
-0.65 vs mean
Adaptive σ
0.41
MIDOS BB
$17.06 – $18.70
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
+0.95
ROE
65.0%
Z +1.35
Rev Gr
24.4%
Z -0.09
EPS Gr
5250.0%
Z +4.42
OPM Gr
52.4%
Z +0.00
FCF Yld
6.4%
Z +0.45
EPS Surp
28.2%
Z +0.18
EPS 3mo Δ
14.8%
Z +0.33
Fwd P/E
15.41
Z —
PEGY
0.00
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-27
Q3M
3.05
Q6M
0.87
Q12M
7.92
MA 30/100
1.046
Bullish (MA30 > MA100)
α (Jensen)
0.2288
β (12M)
0.89
σ (12M)
0.464
Divergence — Fundamentals vs Momentum
Z Percentile
97%
Q Percentile
92%
Divergence
+5.9
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
-0.3
RS Pctl
50%
RS Decile
D5
Persistence
1w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.